FLA14 is a context-dependent term referring to distinct biological entities in different organisms. Below, we delineate its roles in Arabidopsis pollen development and Chlamydomonas flagellar assembly, alongside relevant antibody applications.
Key Findings from Arabidopsis Studies (Source ):
Function:
FLA14 encodes a pollen-specific fasciclin-like arabinogalactan protein (FLA) critical for pollen wall development.
Prevents premature pollen germination under high humidity by maintaining intine (inner pollen wall) integrity.
Localization:
Localizes to the plasma membrane and Hechtian strands (plasma membrane extensions during plasmolysis).
Mutant Phenotypes:
fla14 mutants exhibit precocious germination inside anthers.
Overexpression causes abnormal pollen with thickened intine or collapsed structure, reducing fertility.
ProFLA14::eGFP-GUS transgenic lines confirmed pollen-specific expression via GUS staining and fluorescence microscopy.
Subcellular localization studies used eGFP-FLA14 fusions in onion epidermal cells.
Role in Intraflagellar Transport (IFT) (Sources ):
Function:
FLA14 is a dynein light intermediate chain (LIC) component essential for retrograde IFT, which transports cargo from flagellar tips to cell bodies.
Mutants (fla14) display immotile, shortened flagella filled with IFT particles.
Ubiquitylation:
α-Tubulin ubiquitylation at K304 in fla14 mutants reduces flagellar disassembly rates under stress (e.g., nocodazole treatment).
Antibody Applications (Source ):
cDHC1b and LIC Antibodies:
Western blots confirmed dynein heavy chain (cDHC1b) and LIC levels in fla14 mutants.
Immunofluorescence localized cDHC1b/LIC complexes to peribasal body regions but not flagellar stubs.
| Protein | Localization in fla14 | Flagellar Phenotype |
|---|---|---|
| cDHC1b | Peribasal body region | Immotile, shortened flagella |
| LIC | Peribasal body region | Retrograde IFT failure |
While unrelated to FLA14, FLAD1 (FAD synthetase homolog) antibodies are commercially available and widely used in metabolic studies (Sources ):
| Antibody | Applications | Reactivity | Observed MW |
|---|---|---|---|
| FLAD1 (14118-1-AP) | WB (1:500–1:1000), IF (1:200–800) | Human, Mouse, Rat | 50 kDa, 65–70 kDa |
| FLAD1 (CAB14293) | WB | Human | 49 kDa (predicted) |
Detects FLAD1 in liver tissue (rat/mouse) and cell lines (HepG2, K-562).
Critical for studying FAD biosynthesis in metabolic disorders.
FLA14 Antibody Availability:
No direct commercial antibodies for Arabidopsis or Chlamydomonas FLA14 are cited in the provided sources.
Studies rely on transgenic reporters (e.g., eGFP-FLA14) or dynein complex antibodies (e.g., cDHC1b).
Therapeutic Potential:
Arabidopsis FLA14 manipulation could improve crop fertility under humid conditions.
Chlamydomonas fla14 models aid in understanding ciliary diseases (e.g., Bardet-Biedl syndrome).